Atlanta Consulting Group Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,471
Closed -$796K 134
2024
Q3
$796K Buy
+2,471
New +$808K 0.2% 97

Other funds holding AMGN

Atlanta Consulting Group Advisors's AMGN Position: Q4 2024 in Review

Atlanta Consulting Group Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 2,471 shares — an estimated $796K sold.

Atlanta Consulting Group Advisors first reported a position in AMGN in Q3 2024 and held it in 1 quarter. The position peaked at $796K in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Atlanta Consulting Group Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Atlanta Consulting Group Advisors sold 2,471 Amgen shares in Q4 2024, an estimated $796K.
  • Atlanta Consulting Group Advisors first reported a position in Amgen in Q3 2024 and held it in 1 quarter.
  • Atlanta Consulting Group Advisors's Amgen position peaked at $796K in Q3 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Atlanta Consulting Group Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.